Part of Brands:
We recently participated in ESHRE and look forward to sharing the experience with you. If you missed it, you can watch recordings from our presentations at the Vitrolife Group booth (Booth C006) in Paris.
Contact us to know more
Webinar: ‘Revealing the secrets of the endometrial microbiome’
Dr. Nanko Iwami shares the data from her group studying the treatment of the microbial imbalance in the endometrium through EMMA and ALICE and thereby personalising the endometrial environment to shorten the time to pregnancy.
This presentation was part of Vitrolife Group live Academy Studios from ESHRE 2025.
Watch webinar
Webinar: ‘It is safe to go Fast! – a customer experience with Ultra Rapid Warm Blast’
Using Vitrolife’s Ultra Rapid Warm Blast protocol to warm cryopreserved blastocysts, is a game changer and an efficient way to improve workflow efficiency. Dr. George Koustas presents the data from his lab at Columbia University in New York.
This presentation was part of Vitrolife Group live Academy Studios from ESHRE 2025.
Watch webinar
Webinar: ‘Non invasive PGT-A (EMBRACE) – an update on what is new!’
Presented by Dr. Carmen Rubio. In the second part of presentation, Kamila Gawor from the Invimed clinics in Poland, discuss the use of a non-invasive PGT-A protocol (EMBRACE) and compares its utilisation and results with that of traditional biopsy protocols.
This presentation was part of Vitrolife Group live Academy Studios from ESHRE 2025.
Watch webinar
Webinar: ‘In Vitro Maturation of oocytes – expert opinion’
Prof. William Ledger from City Fertility in Sydney presents data on the use of In Vitro Maturation of oocytes as an alternative to conventional stimulation protocols and highlights the patients who are most likely to benefit from this technique.
This presentation was part of Vitrolife Group live Academy Studios from ESHRE 2025.
Watch webinar
Webinar: ‘Let’s get attached – Prolactin can improve live birth rates’
The use of EmbryoGlue as embryo transfer medium has been well documented over the last 15 years. Dr. Kenji Ezoe from the Kato Ladies Clinic in Tokyo shares his research showing the latest advancements in this product to increase live birth rate and decrease pregnancy loss.
This presentation was part of Vitrolife Group live Academy Studios from ESHRE 2025.
Watch webinar
Webinar: ‘Chromosomal Analysis – beyond the aneuploidies’
In this interview with Andrea Brough and Dr. Salina Kanji from Markham Fertility Centre in Ontario we find out more about how the application of an advanced genetic testing technique like PGT-A Plus can aid clinics to not only improve outcomes but also increase quality control.
This presentation was part of Vitrolife Group live Academy Studios from ESHRE 2025.
Watch webinar
Webinar: ‘Endometrial Receptivity Analysis (ERA) – Improving outcomes for advanced aged patients’
As the only endometrial receptivity test with an RCT, Dr. Tamar Barbakadze from the Georgian-American Centre for Reproductive Medicine shares her data on how selected patients can benefit from the use of ERA to improve clinical outcomes.
This presentation was part of Vitrolife Group live Academy Studios from ESHRE 2025.
Watch webinar
Webinar: ‘More baby laughter! – the More Joy Campaign’
The declining birth rate in many countries around the world is of great concern. Hear from Prof. Edgar Mocanu, former president of the IFFS, how the More Joy campaign hopes to bring awareness to this cause and how you can get involved.
This presentation was part of Vitrolife Group live Academy Studios from ESHRE 2025.
Watch webinar
Webinar: ‘Short insemination combined with Time-lapse incubation’
With the inclusion of new technologies in the IVF laboratory, it is important to review current protocols to see how procedures can be optimised. Dr. Andrew Thompson from IVF Scientific Advisory Services talks about the use of a short insemination protocol combined with Time-lapse imaging.
This presentation was part of Vitrolife Group live Academy Studios from ESHRE 2025.
Watch webinar
Webinar: ‘From embryo to live birth – optimising workflow and the undisturbed culture system’
Elena Linara-Demakakou from The London Woman’s Clinic in the UK shares their results following the successful implementation and utilisation of Vitrolife’s Gx media and Embryoscope to secure even better live birth outcomes.
This presentation was part of Vitrolife Group live Academy Studios from ESHRE 2025.
Watch webinarPowered by the most scientific and clinical support, EMMA&ALICE is the most widely used endometrial microbiome test worldwide and the only commercially available test that delivers an endometrial-specific bacterial panel. Leveraging our experience, we continue to deliver advancements to the analysis and optimization of the endometrial microbiome. We introduce our newest update that includes: We want to bring your attention to the latest independent research, including a groundbreaking randomized controlled trial (RCT) by Barbakadze et al. (2024), which reinforces the effectiveness of ERA in RIF patients. Additional prospective and retrospective studies, case reports, and major meta-analyses (Amin et al., 2022; Jia et al., 2024; Glujovsky et al., 2023, and many more) further validate the clinical relevance of the ERA test. Please explore more information on ERA InsightHub Come and visit us at the booth to discover how our state-of-the-art EmbryoScope feature update can seamlessly integrate with your in-clinic systems — making your workflow smoother, smarter, and more connected. Ultra RapidWarm™ Blast helps embryologists save up to one hour of work time per day. It delivers a clinically proven one-step protocol that warms blastocysts in just minutes—with comparable survival and pregnancy rates. Ultra RapidWarm Blast is used for warming of vitrified human blastocyst-stage embryos. The medium contains 0.25 M sucrose, and is supplied in four 5 ml bottles. Each bottle can be used for two weeks after first opening, if aseptic technique is used and time outside the refrigerator is minimised. The new product innovation is a game-changing procedure: The low sucrose level in Ultra RapidWarm Blast during warming reduces osmotic shock. Studies have shown that low sucrose solutions result in faster re-expansion and higher hatching rates compared to warming in higher sucrose solutions. Furthermore, using a low sucrose solution may result in a more standardised warming protocol with less risk of loosing visual control and exceeding the time in solution. This new solution delivers CNV analysis with ploidy and exogenous DNA contamination detection. Come and talk to us at the booth to find out more about the: ✓ Automation of the entire workflow eWitness contributes greatly to managing the quality of IVF treatment programmes. It prevents critical errors such as mixups of sperm, eggs, and/or embryos. eWitness provides clarity to the user in every step of the process. Don’t hesitate to contact us if you have any questions or want more information about our new products.
Discover our News
EMMA and ALICE just got smarter!
ERA is more than a test – it’s a solution backed by science and trusted by fertility experts around the world
The Scientific Truth About ERA: Latest Evidence
Coming Soon: EmbryoScope x eWitness Integration
Gain 1 Hour Every Single Day with Ultra RapidWarm™ Blast
EmbryoMap SNP elevates your CNV analysis with the addition of SNP detection
The EmbryoMap SNP reagent integrates seamlessly into the existing EmbryoMap workflow.
eWitness optimises lab workflow and enhance security with reliable insights
The IVF treatment process has been in full development in recent years. There is a continuous addition of new features and improved technologies, making operations more and more complex. Securing these process flows is becoming increasingly important.
✓ Monitoring of all actions
✓ Barcodes and RFID on printable labels
✓ Electronic double-checking
Get in touch
Fill out the form below and we’ll get back to you as soon as we can.